The benefits and costs of bisphosphonates.
Coleman
Robert E
RE
University of Sheffield, Hospital, Sheffield, United Kingdom. R.E.Coleman@sheffield.ac.uk
D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D003362:Cost-Benefit Analysis; D004164:Diphosphonates / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D007568:Jaw; D010020:Osteonecrosis / Q000139:chemically induced / Q000191:economics
D050071:Bone Density Conservation Agents; D004164:Diphosphonates